Skip to main content
Journal cover image

Utility of telomerase-pot1 fusion protein in vascular tissue engineering.

Publication ,  Journal Article
Petersen, TH; Hitchcock, T; Muto, A; Calle, EA; Zhao, L; Gong, Z; Gui, L; Dardik, A; Bowles, DE; Counter, CM; Niklason, LE
Published in: Cell Transplant
2010

While advances in regenerative medicine and vascular tissue engineering have been substantial in recent years, important stumbling blocks remain. In particular, the limited life span of differentiated cells that are harvested from elderly human donors is an important limitation in many areas of regenerative medicine. Recently, a mutant of the human telomerase reverse transcriptase enzyme (TERT) was described, which is highly processive and elongates telomeres more rapidly than conventional telomerase. This mutant, called pot1-TERT, is a chimeric fusion between the DNA binding protein pot1 and TERT. Because pot1-TERT is highly processive, it is possible that transient delivery of this transgene to cells that are utilized in regenerative medicine applications may elongate telomeres and extend cellular life span while avoiding risks that are associated with retroviral or lentiviral vectors. In the present study, adenoviral delivery of pot1-TERT resulted in transient reconstitution of telomerase activity in human smooth muscle cells, as demonstrated by telomeric repeat amplification protocol (TRAP). In addition, human engineered vessels that were cultured using pot1-TERT-expressing cells had greater collagen content and somewhat better performance in vivo than control grafts. Hence, transient delivery of pot1-TERT to elderly human cells may be useful for increasing cellular life span and improving the functional characteristics of resultant tissue-engineered constructs.

Duke Scholars

Published In

Cell Transplant

DOI

EISSN

1555-3892

Publication Date

2010

Volume

19

Issue

1

Start / End Page

79 / 87

Location

United States

Related Subject Headings

  • Transfection
  • Tissue Engineering
  • Telomere-Binding Proteins
  • Telomerase
  • Shelterin Complex
  • Recombinant Fusion Proteins
  • Rats, Nude
  • Rats
  • Neurology & Neurosurgery
  • Muscle, Smooth, Vascular
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Petersen, T. H., Hitchcock, T., Muto, A., Calle, E. A., Zhao, L., Gong, Z., … Niklason, L. E. (2010). Utility of telomerase-pot1 fusion protein in vascular tissue engineering. Cell Transplant, 19(1), 79–87. https://doi.org/10.3727/096368909X478650
Petersen, Thomas H., Thomas Hitchcock, Akihito Muto, Elizabeth A. Calle, Liping Zhao, Zhaodi Gong, Liqiong Gui, et al. “Utility of telomerase-pot1 fusion protein in vascular tissue engineering.Cell Transplant 19, no. 1 (2010): 79–87. https://doi.org/10.3727/096368909X478650.
Petersen TH, Hitchcock T, Muto A, Calle EA, Zhao L, Gong Z, et al. Utility of telomerase-pot1 fusion protein in vascular tissue engineering. Cell Transplant. 2010;19(1):79–87.
Petersen, Thomas H., et al. “Utility of telomerase-pot1 fusion protein in vascular tissue engineering.Cell Transplant, vol. 19, no. 1, 2010, pp. 79–87. Pubmed, doi:10.3727/096368909X478650.
Petersen TH, Hitchcock T, Muto A, Calle EA, Zhao L, Gong Z, Gui L, Dardik A, Bowles DE, Counter CM, Niklason LE. Utility of telomerase-pot1 fusion protein in vascular tissue engineering. Cell Transplant. 2010;19(1):79–87.
Journal cover image

Published In

Cell Transplant

DOI

EISSN

1555-3892

Publication Date

2010

Volume

19

Issue

1

Start / End Page

79 / 87

Location

United States

Related Subject Headings

  • Transfection
  • Tissue Engineering
  • Telomere-Binding Proteins
  • Telomerase
  • Shelterin Complex
  • Recombinant Fusion Proteins
  • Rats, Nude
  • Rats
  • Neurology & Neurosurgery
  • Muscle, Smooth, Vascular